NASDAQ: CYTK · Life Sciences · 8 alerts · CIK 1061983
Share price
$53.17Close, Nov 16
Market cap
$7.41B
Shares outstanding
139.3MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Cytokinetics Inc filings on SEC EDGAR ↗
Cytokinetics Insider B. Lynne Parshall Sells $274K of Stock
B. Lynne Parshall sold 5,000 shares of Cytokinetics Inc at $54.17 to $55.26 a share (average $54.73) in 2 transactions, worth $274K in total on Nov 9, 2026. Shares held after the trade: 5,784 (-30.6%).
Cytokinetics EVP Research & Development Fady Ibraham Malik Sells $220K of Stock
Fady Ibraham Malik, EVP Research & Development, sold 3,500 shares of Cytokinetics Inc at $62.93 a share, worth $220K in total on Nov 3, 2026. Shares held after the trade: 153,902 (-2.2%).
Cytokinetics President & CEO Robert I. Blum Sells $471K of Stock
Robert I. Blum, President & CEO, sold 7,500 shares of Cytokinetics Inc at $62.81 a share, worth $471K in total on Nov 2, 2026. Shares held after the trade: 278,544 (-2.6%).
Cytokinetics EVP Research & Development Fady Ibraham Malik Sells $224K of Stock
Fady Ibraham Malik, EVP Research & Development, sold 3,500 shares of Cytokinetics Inc at $64.01 a share, worth $224K in total on Oct 20, 2026. Shares held after the trade: 153,902 (-2.2%).